# Independent biological/function result review

Scope: independently read pilot/RESULT.json, SUMMARY.json, and RUN_RECEIPT.json; recalculate reported aggregate relative changes from those scalars and inspect each seed's functional metrics. No model/import of root implementation, fit, checkpoint, prediction array, new source, or additional biological outcome was read. This is an independent interpretation/scalar-consistency review, not a raw-array replication. Peer result reviews were not read before this seal.

## Result and decision

The authoritative receipt is COMPLETED with returncode0. The exposed-source pilot uses 391 training contexts and 101 development contexts from 90 patient groups, with 123 retained drug columns. The frozen continuation requirement fails. **STOP_EXPANDING_THIS_FIXED_CONSISTENCY_CONFIGURATION** is supported; no tuning or extra experiment is requested.

| Method | Patient-average raw AUC MSE | Query-only top3 regret |
|---|---:|---:|
| Source mean | 2685.317079 | 43.627763 |
| Ordinary conditional covariance | 2054.557791 | 37.054722 |
| Randomized/augmented updater, 3-seed mean | 2116.203832 | 38.974889 |
| Consistency updater, 3-seed mean | 2143.422020 | 38.683091 |
| Invariant set predictor, 3-seed mean | 2211.235133 | 39.824282 |

Consistency reduces mean standardized order sensitivity by approximately **56.64%** and partition sensitivity by **57.35%** relative to augmentation. That numerical effect does not translate into the required functional improvement: MSE is **1.286% worse** on seed average and worse in each seed (about 0.991%, 1.598%, 1.270%). Mean shortlist regret is **0.749% lower**, but improvement is confined to seed0; it is worse in seeds1 and2. No seed improves both required functional metrics. Relative to ordinary covariance, consistent is approximately **4.325% worse in MSE and 4.394% worse in regret**. Exact invariance of the set predictor also does not yield the best functional result. Invariance is therefore an insufficient success metric here.

## Actual positive and its limits

Ordinary conditional covariance improves over source mean by approximately **23.49% in MSE and 15.07% in query shortlist regret**. This is a useful exposed-source signal: eight same-context purchased functional observations contain information for completing other available drug responses. It is consistent with ordinary panel correlation/conditional prediction. It does not establish a biological action-strength mechanism, a virtual-cell representation, autonomous acquisition value, transferable updater superiority, or RSI. Baseline response correlations can reflect broad patient sensitivity, assay factors, panel selection, shared mechanisms, or combinations; this pilot does not separate them.

The mean method does not condition on the eight support outcomes; covariance does. Thus this positive is feedback value relative to an unconditioned baseline, not evidence that a new updater beats strong same-information methods. No causal fraction or clinical benefit is inferred.

## Biological and measurement contract

The top3 metric is evaluated among **unbought, finite query drug entries**, with panel-specific raw AUC conventions; it is not whole-panel nomination including acquired drugs, clinical treatment choice, or a calibrated cross-drug potency comparison. Different assayed drug concentration ranges, normalization, availability, or missingness mechanisms can affect its meaning. These concerns constrain biological interpretation but do not erase the frozen digital comparison shared by all arms. No physical simultaneity or treatment-order exchangeability is inferred from column permutations.

The historical exposed fold0 remains exploratory development. Seeds0/1/2 reuse the same patient contexts and fixed support observations; they are robustness runs, not three independent biological tasks. The pilot applies one finite120-step configuration. It provides no external confirmation, practical minimum-effect calibration, or full budget-matched comparison to all direct, refit, continual, active, mixture, or program-search alternatives.

## Strongest alternative explanations and stop scope

The consistency penalty may reduce effective step sizes/response amplitude, trading responsiveness for order stability. Alternatively, limited training could leave some arms undertrained, and the set model's parameterization or initial learning rate could be poorly matched to the fixed budget. These are **unverified explanations**, not observed mechanisms; no checkpoint audit or intervention on learned steps was performed here. They do not override the predeclared stop or justify post-result hyperparameter expansion. The result rejects the claimed advantage of this specific configuration, not every conceivable consistency objective, model size, or computational budget.

The covariance sentinel's advantage can have an ordinary statistical explanation and is already enough to block promotion of this instantiated nonlinear updater. Its near-zero computation for the saved conditional calculation is not total historical assay/data-processing cost. All methods' source replays and repeated query predictions remain computational evaluations of old measurements, not new experimental feedback.

Next action: preserve the negative functional result and the ordinary feedback positive, perform only the requested result cross-examination, and do not expand this fixed configuration. No world-model, agent, inheritance, joint or improved-improver evidence is added.
